FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates
Released On
March 27, 2023
Expires On
March 27, 2024
Media Type
Internet
Completion Time
30 minutes
Specialty
Allergy & Immunology, Pediatrics, Primary Care
Topic(s)
Allergies, Anaphylaxis
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Aimmune Therapeutics, Inc.
Credit Available
- Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)™
- Nurses — 0.5 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is directed toward allergist/immunologists, internists, pediatricians, nurse practitioners, physician assistants, and registered nurses. Other health care professionals involved in the management of patients with food allergy will be invited to participate as well.
Activity Overview
The PER FAQ™ is an innovative video-based activity that features a clinical expert answering questions submitted by learners who participated in a related PER Postgame™ activity. It is intended to provide useful commentary about important research-related or point-of-care focused questions that many clinicians face in daily practice. This activity is based on the PER Postgame™ activity PER Postgame™: The Latest from Louisville 2022 – Utilizing Recent Data to Improve Care for Patients with Peanut Allergy that reviews abstracts presented at relevant 2022 annual allergy meetings regarding clinical trial data for current and emerging therapies for peanut allergy.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Analyze recent efficacy and safety data of novel oral immunotherapy (OIT) agents that have the potential to substantially impact outcomes in patients with peanut allergies
- Design optimal treatment plans for toddlers with peanut allergies based on the latest clinical trial data findings regarding OIT agents
Faculty
Edwin H. Kim, MD MS
Associate Professor, Pediatrics and Medicine
Department of Medicine
Division of Rheumatology, Allergy, and Immunology
Division Chief, UNC Pediatric Allergy & Immunology
Director, UNC Allergy & Immunology Fellowship Program
Director, UNC Food Allergy Initiative
University of North Carolina School of Medicine
Chapel Hill, NC
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 0.5 Contact Hours.
Disclosures of Conflicts of Interest
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
- Edwin H. Kim, MD MS
- Grant/Research Support: FARE, NIH-NIAID
- Consultant: ALK, Allergy Therapeutics, Belhaven Biopharma, Genentech, Kenota Health, Nutricia, Ukko
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.